Home sleep apnea testing has become standard practice for many patients, and for good reason—it’s more convenient than in-lab studies, less expensive, and for straightforward obstructive sleep apnea cases, provides adequate diagnostic information. But the expanding use of home testing means more patients are being evaluated with tools that have real limitations, and not everyone understands what those limitations mean for their results.

The fundamental difference is that home sleep tests measure fewer parameters than in-lab polysomnography. A typical home test tracks airflow, respiratory effort, and oxygen saturation—enough to identify apneas and hypopneas. What it doesn’t measure is actual sleep. There’s no EEG monitoring, so the device can’t distinguish sleep from wake.

This matters because the AHI (apnea-hypopnea index) calculation depends on the denominator. In-lab studies divide the number of respiratory events by actual sleep time measured via EEG. Home tests typically divide by total recording time, which includes time the patient was awake. If you spent an hour lying awake before falling asleep, or woke up several times during the night, the home test will underestimate your AHI by inflating the denominator.

For patients with severe OSA who have events throughout the night, this underestimation usually doesn’t change the clinical picture—they still meet diagnostic criteria easily. For patients with mild disease near the diagnostic threshold, the underestimation can mean the difference between a positive and negative test result.

I’ve seen patients with clear clinical symptoms of sleep apnea get borderline or negative home sleep test results, who then get in-lab studies showing moderate OSA. The difference wasn’t that they had different disease severity on the two nights—it was that the home test’s lack of sleep monitoring led to an artificially low AHI calculation.

Another limitation is that home tests don’t detect many sleep disorders other than OSA. If your problem is central sleep apnea, periodic limb movements, REM behavior disorder, or any parasomnias, a standard home sleep test will likely miss it or provide ambiguous results. The device is designed and validated specifically for obstructive sleep apnea detection.

This creates diagnostic challenges for patients with symptoms that could have multiple causes. Someone with unexplained daytime sleepiness, poor sleep quality, and a negative home sleep test hasn’t necessarily ruled out sleep pathology—they’ve ruled out moderate to severe OSA. There could still be mild OSA that the home test underestimated, or a different sleep disorder the home test can’t detect.

The quality of home sleep test data varies significantly based on patient compliance with setup instructions. In-lab studies have technicians ensuring sensors are correctly positioned and functioning throughout the night. Home tests rely on patients following written or video instructions to attach sensors themselves. Unsurprisingly, this leads to more technical failures and poor-quality data.

Common problems include nasal cannulas that shift during the night and stop measuring airflow, effort belts that loosen and no longer detect respiratory effort accurately, and pulse oximeters that fall off fingers. When any sensor fails, the study may become uninterpretable or provide misleading results. Most home sleep test programs report technical failure rates of 10-20%, requiring repeat testing.

Patient selection matters enormously for home sleep test accuracy. The guidelines suggest home testing is appropriate for patients with high pretest probability of moderate to severe OSA without significant comorbidities. In that population, home tests perform well. Expand beyond those criteria—patients with heart failure, significant lung disease, neurological conditions, or suspicion of non-OSA sleep disorders—and home test limitations become more problematic.

Unfortunately, the convenience and cost advantages of home testing create pressure to use it more broadly than the validated populations. Insurance companies prefer the lower cost. Patients prefer avoiding an overnight stay in a sleep lab. Clinics like the operational simplicity. These incentives push home testing into scenarios where in-lab studies would provide better diagnostic information.

Positional variation in OSA is another area where home tests provide less information. Some patients have significant OSA only when sleeping on their back. In-lab studies with video monitoring can correlate events with sleep position. Most home tests don’t include positional monitoring, so they can’t tell you whether your apneas are position-dependent. That information affects treatment recommendations—positional therapy might be sufficient if OSA only occurs supine, but won’t help if events happen in all positions.

The business model of some home sleep testing programs creates additional concerns. Third-party companies provide home testing kits, interpret the results, and then funnel positive results toward CPAP sales from affiliated suppliers. The financial incentive to over-diagnose OSA in borderline cases is obvious, and while most companies maintain appropriate diagnostic standards, the potential for conflict of interest exists.

I’m not suggesting home sleep testing is unreliable or inappropriate—for many patients, it’s entirely suitable. But physicians and patients should understand its limitations. A negative home sleep test in a patient with classic OSA symptoms might warrant in-lab confirmation. Borderline results might need clinical judgment about whether treatment should be offered despite subthreshold AHI. Patients with complex medical histories might need in-lab evaluation from the start.

What frustrates me is when home sleep testing gets treated as equivalent to polysomnography for all purposes, rather than a useful but more limited tool that works well in specific contexts. The clinical guidelines are actually pretty clear about appropriate use, but real-world practice doesn’t always follow them.

If you’re getting a home sleep test, ask about the specific device being used and what parameters it measures. Understand that a negative result rules out moderate to severe OSA but doesn’t necessarily explain your symptoms if you have them. And if the results don’t match your clinical picture—you have clear symptoms but a negative or borderline test—advocate for further evaluation rather than assuming sleep pathology has been ruled out.

Home sleep testing represents good progress in making sleep medicine more accessible. We just need to use it appropriately and recognize when its limitations matter for a particular patient’s situation.